Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2005 3
2007 1
2008 1
2009 3
2010 3
2012 1
2014 2
2015 2
2016 2
2017 4
2018 3
2019 4
2020 5
2021 5
2022 2
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Results by year

Filters applied: . Clear all
Page 1
Propranolol.
Al-Majed AA, Bakheit AHH, Abdel Aziz HA, Alajmi FM, AlRabiah H. Al-Majed AA, et al. Profiles Drug Subst Excip Relat Methodol. 2017;42:287-338. doi: 10.1016/bs.podrm.2017.02.006. Epub 2017 Apr 6. Profiles Drug Subst Excip Relat Methodol. 2017. PMID: 28431779
Losartan: Comprehensive Profile.
Al-Majed AR, Assiri E, Khalil NY, Abdel-Aziz HA. Al-Majed AR, et al. Profiles Drug Subst Excip Relat Methodol. 2015;40:159-94. doi: 10.1016/bs.podrm.2015.02.003. Epub 2015 Apr 9. Profiles Drug Subst Excip Relat Methodol. 2015. PMID: 26051686 Review.
Preface.
Al-Majed AA. Al-Majed AA. Profiles Drug Subst Excip Relat Methodol. 2023;48:ix. doi: 10.1016/S1871-5125(23)00009-2. Profiles Drug Subst Excip Relat Methodol. 2023. PMID: 37061277 No abstract available.
Lodenafil.
Alshehri YM, Al-Majed AA, Attwa MW, Bakheit AH. Alshehri YM, et al. Among authors: al majed aa. Profiles Drug Subst Excip Relat Methodol. 2022;47:113-147. doi: 10.1016/bs.podrm.2021.10.004. Epub 2021 Dec 7. Profiles Drug Subst Excip Relat Methodol. 2022. PMID: 35396013 Review.
Mirtazapine.
Al-Majed A, Bakheit AH, Alharbi RM, Abdel Aziz HA. Al-Majed A, et al. Profiles Drug Subst Excip Relat Methodol. 2018;43:209-254. doi: 10.1016/bs.podrm.2018.01.002. Epub 2018 Mar 30. Profiles Drug Subst Excip Relat Methodol. 2018. PMID: 29678261 Review.
Azilsartan medoxomil.
Al-Majed AA, Bakheit AHH, Al-Muhsin A, Al-Kahtani HM, Abdelhameed AS. Al-Majed AA, et al. Profiles Drug Subst Excip Relat Methodol. 2020;45:1-39. doi: 10.1016/bs.podrm.2019.10.001. Epub 2019 Dec 6. Profiles Drug Subst Excip Relat Methodol. 2020. PMID: 32164965 Review.
Preface.
Al-Majed AA. Al-Majed AA. Profiles Drug Subst Excip Relat Methodol. 2021;46:ix-x. doi: 10.1016/S1871-5125(21)00009-1. Profiles Drug Subst Excip Relat Methodol. 2021. PMID: 33461702 No abstract available.
Emtricitabine.
Al-Majed AA, Bakheit AHH, Al-Qahtani BM, Al-Kahtani HM, Abdelhameed AS. Al-Majed AA, et al. Profiles Drug Subst Excip Relat Methodol. 2020;45:55-91. doi: 10.1016/bs.podrm.2019.10.003. Epub 2019 Dec 6. Profiles Drug Subst Excip Relat Methodol. 2020. PMID: 32164970
Olmesartan.
Al-Majed AA, Bakheit AHH, Abdel Aziz HA, Al-Jallal AAM. Al-Majed AA, et al. Profiles Drug Subst Excip Relat Methodol. 2017;42:241-286. doi: 10.1016/bs.podrm.2017.02.005. Epub 2017 Mar 31. Profiles Drug Subst Excip Relat Methodol. 2017. PMID: 28431778
Clenbuterol Hydrochloride.
Al-Majed AA, Khalil NY, Khbrani I, Abdel-Aziz HA. Al-Majed AA, et al. Profiles Drug Subst Excip Relat Methodol. 2017;42:91-123. doi: 10.1016/bs.podrm.2017.02.002. Epub 2017 Mar 31. Profiles Drug Subst Excip Relat Methodol. 2017. PMID: 28431781
37 results